C90 Low aspects patient treated with mechanical thrombectomy with malignant edema without neurological deterioration

<h3>Introduction</h3> Previous RCTs and meta-analyses support the use of mechanical thrombectomy (MT) in low-ASPECTS patients. However, questions remain about edema prevention, patient management, and criteria for decompressive craniectomy (DC), especially since studies on DC predate low-ASPECTS trials. <h3>Case Description</h3> We present the case of a 49-year old man with left hemiparesis, hemianopia, and dysarthria. The symptoms began on December 29 at 9:00 PM. He was transported by ambulance to the nearest hospital at 10:00 PM, NIHSS-14. Initial NCCT and CTA revealed M1 occlusion of the right MCA. IV tPA was initiated, and he was transferred to the nearest stroke center. The patient arrived at the stroke center on December 30 at 1:00 AM with an NIHSS- 15. Neuroimagine on figure 1 Based on National Standard and evidence from low-ASPECTS trials, MT was performed. Result-eTICI 2b67%. After MT patient was received hypertonic saline, paracetamol, and followed the FESS protocol. sBP was maintained &lt;140 mmHg. Mobilization was delayed until 72 hours. All measures were used for the potential reduction of the edema. Clinical progress and neuroimagine are presented on figure 2 <b>Discharge -</b> NIHSS-7; mRS-3. <h3>Conclusions</h3> This case illustrates the challenges and benefits of MT in these patients. We need further international collaboration and trials. Future research should focus on improving the management of these patients after MT, creating new criteria for DC, identifying pharmacological agents to reduce the risk of malignant edema and prevent rapid neurological deterioration in this patient group. <h3>Conflict of Interest</h3> No

Authors

Institutions

Publication Details

Published
2025-09-01
DOI
https://doi.org/10.1136/jnis-2025-esmint.239
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

C90 Low aspects patient treated with mechanical thrombectomy with malignant edema without neurological deterioration

Andriy Holiaka, Dmytro Hrynykha, Dmytro Lebedynets, Yevgen Butsko
Cancer Treatment and Pharmacology
article

C90 Low aspects patient treated with mechanical thrombectomy with malignant edema without neurological deterioration

Andriy Holiaka, Dmytro Hrynykha, Dmytro Lebedynets, Yevgen Butsko
article en

Abstract

<h3>Introduction</h3> Previous RCTs and meta-analyses support the use of mechanical thrombectomy (MT) in low-ASPECTS patients. However, questions remain about edema prevention, patient management, and criteria for decompressive craniectomy (DC), especially since studies on DC predate low-ASPECTS trials. <h3>Case Description</h3> We present the case of a 49-year old man with left hemiparesis, hemianopia, and dysarthria. The symptoms began on December 29 at 9:00 PM. He was transported by ambulance to the nearest hospital at 10:00 PM, NIHSS-14. Initial NCCT and CTA revealed M1 occlusion of the right MCA. IV tPA was initiated, and he was transferred to the nearest stroke center. The patient arrived at the stroke center on December 30 at 1:00 AM with an NIHSS- 15. Neuroimagine on figure 1 Based on National Standard and evidence from low-ASPECTS trials, MT was performed. Result-eTICI 2b67%. After MT patient was received hypertonic saline, paracetamol, and followed the FESS protocol. sBP was maintained &lt;140 mmHg. Mobilization was delayed until 72 hours. All measures were used for the potential reduction of the edema. Clinical progress and neuroimagine are presented on figure 2 <b>Discharge -</b> NIHSS-7; mRS-3. <h3>Conclusions</h3> This case illustrates the challenges and benefits of MT in these patients. We need further international collaboration and trials. Future research should focus on improving the management of these patients after MT, creating new criteria for DC, identifying pharmacological agents to reduce the risk of malignant edema and prevent rapid neurological deterioration in this patient group. <h3>Conflict of Interest</h3> No

Kyiv City Clinical Oncology Center (UA)
Openalex Percentile: Top 67%
Cancer Treatment and Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.